Large-scale tissue platform Vivodyne operates the world’s largest human biological datacenter with 12 robotic HIVE laboratories and capacity to run 3.1 million large human tissue trials annually, presenting a compelling opportunity to scale preclinical testing services for partners seeking high-throughput, human-relevant data.

Series 2 TissueDisk The launch of Series 2 TissueDisk enabling hundreds of functional human tissues to be grown simultaneously creates a strong upsell path for pharmaceutical and biotech clients needing parallelized tissue-based assays and accelerated lead optimization.

Animal-free focus Vivodyne is positioning itself as an automated, animal-testing replacement platform, appealing to companies pursuing 3Rs compliance and faster regulatory-ready data, which could translate into pilot programs with sponsors seeking humane, scalable alternatives.

Robotics and AI edge With robotic HIVE laboratories and AI-driven testing, Vivodyne can offer integrated end-to-end preclinical services, enabling partners to shorten discovery timelines and reduce manual labor, ideal for collaborations, CRO partnerships, and co-development deals.

Strategic expansion Recent investments and expansion to South San Francisco and the broader growth in capacity signal readiness for partner-led pilots, licensing conversations, and joint ventures to leverage their rapidly scalable tissue platforms at scale.